Showing results (191-200 of 212) with videos related to

Sort By:
Pageof 22
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2015
CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in miceJulia Weber, Rupert Öllinger, Mathias Friedrich, et al.
Nature Medicine|May 30, 2018
Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphataseDietrich A Ruess, Guus J Heynen, Katrin J Ciecielski, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 17, 2024
A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis InductionCarolin Schneider, Jorina Hilbert, Franziska Genevaux, et al.
JCI Insight|May 27, 2025
Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real timeKatja Wittenzellner, Manuel Lengl, Stefan Röhrl, et al.
Cancer Discovery|July 20, 2021
Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary CancerChiara Falcomatà, Stefanie Bärthel, Angelika Ulrich, et al.
Science (New York, N.Y.)|March 17, 2023
Decrypting drug actions and protein modifications by dose- and time-resolved proteomicsJana Zecha, Florian P Bayer, Svenja Wiechmann, et al.
The Journal of Clinical Investigation|August 22, 2023
Phenotype screens of murine pancreatic cancer identify a Tgf-α-Ccl2-paxillin axis driving human-like neural invasionXiaobo Wang, Rouzanna Istvanffy, Linhan Ye, et al.
Nature Communications|March 2, 2018
Single cell polarity in liquid phase facilitates tumour metastasisAnna Lorentzen, Paul F Becker, Jan Kosla, et al.
Cancer Cell|June 23, 2023
An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targetsJoscha Griger, Sebastian A Widholz, Moritz Jesinghaus, et al.
Medcomm|June 10, 2026
The Protein Phosphatase Inhibitor LB100 Targets the Mesenchymal Lineage of Pancreatic Ductal AdenocarcinomaJanine Murr, Carolin Schneider, Ningjun Duan, et al.
Pageof 22